1,267 posters, 47 videos, 13 topics, 4 sessions, 853 authors
ePostersLive by SciGen Technologies S.A. All rights reserved.
SOHO 2026 Annual Meeting
September 9 - 12, 2026 | George R. Brown Convention Center, Houston, Texas
Posters
Showing 1,267 results.
CML - 1127
Digital PCR versus qPCR for BCR::ABL1 Monitoring and Treatment-Free Remission Prediction in Chronic Myeloid Leukemia: A Systematic Review and Meta-Analysis
Amal Paul
Poster Presenter: Amal Paul
CML - 1129
Sequential Enumeration of CD26+ Leukemic Stem Cells and Its Correlation With BCR::ABL1 Transcript Levels in Chronic Myeloid Leukemia at Diagnosis and During Tyrosine Kinase Inhibitor Therapy
Praveen Sharma
Poster Presenter: Praveen Sharma
CML - 1134
Efficacy and Safety of Asciminib Dose Escalation in Patients with Chronic Myeloid Leukemia (CML) without Optimal Response to the Standard Dose
Elza Lomaia
Poster Presenter: Elza Lomaia
CML - 115
Phenotype-Specific Safety Reporting Signals of Asciminib Versus Second- and Third-Generation Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia: A FAERS Disproportionality Analysis
Edward Mwarangu
Poster Presenter: Edward Mwarangu
CML - 1166
Cardiac Safety of Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia: A Real-World Propensity-Matched Comparison of Dasatinib, Nilotinib, and Imatinib
Rukash Khan Niazi
Poster Presenter: Rukash Khan Niazi
CML - 1215
A Novel BCR::ABL1 I502T Mutation Associated With Acquired Asciminib Resistance in Chronic-Phase Chronic Myeloid Leukemia
Rahul Kumar Thakur
Poster Presenter: Rahul Kumar Thakur
CML - 1221
Early CD26? Leukemic Stem Cell Kinetics Can Predict Suboptimal Molecular Response and Switching TKIs during Chronic-Phase CML Therapy
Rudra Narayan Swain
Poster Presenter: Rudra Narayan Swain
CML - 1247
Atherothrombotic adverse effects of tyrosine kinase inhibitors in patients with chronic myeloid leukemia
Nadezhda Shnalieva
Poster Presenter: Nadezhda Shnalieva